Actively Recruiting
Understanding immunE-related toXicities by multifACeT Profiling
Led by Royal Marsden NHS Foundation Trust · Updated on 2025-10-01
200
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A prospective observational cohort study of patients undergoing CPI therapy in which translational research is the fundamental aspect of the study.
CONDITIONS
Official Title
Understanding immunE-related toXicities by multifACeT Profiling
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Written informed consent
- Age 18 years or older
- Confirmed diagnosis of any form of solid malignancy with a clinical indication and appropriate treatment plan to commence immune checkpoint inhibitor therapy
You will not qualify if you...
- Medical or psychological condition that would preclude informed consent
- Planned participation in a drug trial receiving investigational agents
- Subjects who have previously commenced immune checkpoint inhibitor therapy prior to study entry
- Subjects unable to comply with the study or sample schedule
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Royal Marsden NHS Foundation Trust
Chelsea, London, United Kingdom, SW3 6JJ
Actively Recruiting
Research Team
L
Laura Boddy
CONTACT
A
Arjun Modi
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here